|
Conclusion:
"This study demonstrated the usefulness of the antibody-bead array approach in
finding signatures that may be specific for primary non-metastatic breast cancer and
illustrated the potential for early detection of breast cancer. This approach also revealed
serum markers related to clinical and pathological features, including receptor
expression status in tissue, and provided more general systemic information concerning
responses in breast cancer patients. Further validation is required before the multiplex
bead array approach is routinely used for screening, monitoring, prediction, and
prognosis purposes."
|